Top compounds associated with response to RP11-812E19.9


Feature Type Standardized
Nominal ANOVA
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.031 0.3
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC -0.073 0.3
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.038 0.3
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.034 0.3
mRNA PD318088 CTRPv2 pan-cancer AAC -0.035 0.3
Download CSV